Neurovalens - Crunchbase Company Profile & Funding

Q: Where is Neurovalens's headquarters?

Neurovalens is located in Belfast, Belfast, United Kingdom.

Q: Who invested in Neurovalens?

Neurovalens has 15 investors including U.S. Food and Drug Administration And Beltrae Partners.

Q: When was the last funding round for Neurovalens?

Neurovalens closed its last funding round on obfuscated from a Grant round.

Q: How much funding has Neurovalens raised to date?

Neurovalens has raised obfuscated.

Overview

Neurovalens

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

+2 more milestones

See more interactive data and historical milestones on desktop for the best experience

About Neurovalens

CB Rank

6041

Neurovalens delivers innovative solutions in the field of neuroscience, bioscience and neurophysiology

Founded

obfuscation

Private

Grant

Belfast, Belfast, United Kingdom

1-10

neurovalens.com/

Biotechnology

Health Care

Life Science

Neuroscience

Funding Rounds

Grant

OBF

obfuscation

Venture - Series Unknown

OBF

obfuscation

Debt Financing

OBF

obfuscation

Key People

Tom Bilyeu: Advisor
Past Role: Quest Nutrition, Co-Founder and President
Paul McGeoch: CHIEF SCIENTIFIC OFFICER

Details

Legal Name

Neurovalens Ltd

Operating Status

Active

Company Type

For Profit

Founders

Jason McKeown, Paul McGeoch

About the Company

Neurovalens delivers innovative solutions in the field of neuroscience, bioscience and

neurophysiology.Neurovalens has received support from Invest NI under the European Union’s Investment for Growth and Jobs Programme. The project, recorded on the ERDF beneficiaries’ website, will be implemented over the next one year, undertaking research and

development activities aimed at improving the competitiveness of the business.

Predictions & Insights

Growth Insight

See this Growth Insight

Neurovalens is

Lorem

to be growing

Top Contributing Factors

Recently Raised Funding

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Key Employee Changes

Products & Services

Modius Sleep

An FDA-cleared, non-invasive neurostimulation device for home use to treat chronic insomnia by stimulating the vestibular nerve to improve sleep quality.

Modius Stress

An FDA-cleared, non-invasive neurostimulation device designed to treat anxiety by modulating brain activity through vestibular nerve stimulation.

Research & Development

Neurovalens is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Grant - Neurovalens	1	obfuscated obfuscation	U.S. Food and Drug Administration	Grant
obfuscated obfuscation	Grant - Neurovalens	1	obfuscated obfuscation	U.S. Food and Drug Administration	Grant
obfuscated obfuscation	Grant - Neurovalens	1	obfuscated obfuscation	U.S. Food and Drug Administration	Grant
obfuscated obfuscation	Grant - Neurovalens	1	obfuscated obfuscation	U.S. Food and Drug Administration	Grant
obfuscated obfuscation	Grant - Neurovalens	1	obfuscated obfuscation	U.S. Food and Drug Administration	Grant

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Grant - Neurovalens	1	obfuscated obfuscation	U.S. Food and Drug Administration	Grant
obfuscated obfuscation	Grant - Neurovalens	1	obfuscated obfuscation	U.S. Food and Drug Administration	Grant
obfuscated obfuscation	Grant - Neurovalens	1	obfuscated obfuscation	U.S. Food and Drug Administration	Grant
obfuscated obfuscation	Grant - Neurovalens	1	obfuscated obfuscation	U.S. Food and Drug Administration	Grant
obfuscated obfuscation	Grant - Neurovalens	1	obfuscated obfuscation	U.S. Food and Drug Administration	Grant

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
U.S. Food and Drug Administration	Yes	Grant - Neurovalens	—
U.S. Food and Drug Administration	Yes	Grant - Neurovalens	—
U.S. Food and Drug Administration	Yes	Grant - Neurovalens	—
U.S. Food and Drug Administration	Yes	Grant - Neurovalens	—
U.S. Food and Drug Administration	Yes	Grant - Neurovalens	—